| This article has been cited by |
| 1 | How low can you go? Use of low- and standard-dose liposomal amphotericin B for treatment of invasive fungal infections | |
| Zahra Kassamali,Larry H. Danziger,Robert C. Glowacki,David N. Schwartz |
| International Journal of Infectious Diseases.2013;17(8)e615 |
| [DOI] |
|
| 2 | How low can you go? Use of low- and standard-dose liposomal amphotericin B for treatment of invasive fungal infections | |
| Martin Schmidt-Hieber |
| International Journal of Infectious Diseases.2015;17(8)211 |
| [DOI] |
|
| 3 | Burden of Serious Fungal Infections in Jordan | |
| Jamal Wadi,David Denning |
| Journal of Fungi.2018;4(1)15 |
| [DOI] |
|
| 4 | Comparative Effectiveness of Induction Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: A Network Meta-Analysis | |
| Jeffrey I. Campbell,Steve Kanters,John E. Bennett,Kristian Thorlund,Alexander C. Tsai,Edward J. Mills,Mark J. Siedner |
| Open Forum Infectious Diseases.2015;2(1)15 |
| [DOI] |
|
| 5 | Access to antifungal medicines in resource-poor countries – Authors' reply | |
| Angela Loyse,Harry Thangaraj,Nelesh P Govender,Thomas Harrison,Tihana Bicanic |
| The Lancet Infectious Diseases.2014;14(5)371 |
| [DOI] |
|
| 6 | CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)—Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) | |
| M. Schmidt-Hieber,G. Silling,E. Schalk,W. Heinz,J. Panse,O. Penack,M. Christopeit,D. Buchheidt,U. Meyding-Lamadé,S. Hähnel,H.H. Wolf,M. Ruhnke,S. Schwartz,G. Maschmeyer |
| Annals of Oncology.2016;27(7)1207 |
| [DOI] |
|
| 7 | New Insights into HIV/AIDS-Associated Cryptococcosis | |
| Spinello Antinori |
| ISRN AIDS.2013;2013(7)1 |
| [DOI] |
|
| 8 | Complexing amphotericin B with gold nanoparticles improves fungal clearance from the brains of mice infected with Cryptococcal neoformans | |
| Koteswara R Chintalacharuvu,Zlatko A Matolek,Benny Pacheco,Erick M Carriera,David O Beenhouwer |
| Medical Mycology.2021;59(11)1085 |
| [DOI] |
|
| 9 | In vitroantifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole | |
| Shivaprakash M. Rudramurthy,Manu Jatana,Rachna Singh,Arunaloke Chakrabarti |
| Mycoses.2013;56(1)39 |
| [DOI] |
|
| 10 | Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries | |
| Angela Loyse,Harry Thangaraj,Philippa Easterbrook,Nathan Ford,Monika Roy,Tom Chiller,Nelesh Govender,Thomas S Harrison,Tihana Bicanic |
| The Lancet Infectious Diseases.2013;13(7)629 |
| [DOI] |
|
| 11 | Equity in clinical trials for HIV-associated cryptococcal meningitis: A systematic review of global representation and inclusion of patients and researchers | |
| David S. Lawrence,Tshepo Leeme,Mosepele Mosepele,Thomas S. Harrison,Janet Seeley,Joseph N. Jarvis,Joseph M. Vinetz |
| PLOS Neglected Tropical Diseases.2021;15(5)e0009376 |
| [DOI] |
|
| 12 | Access to antifungal medicines in resource-poor countries | |
| Manoj P Jadhav,Nilima A Kshirsagar |
| The Lancet Infectious Diseases.2014;14(5)370 |
| [DOI] |
|
| 13 | Isolated cervical cryptococcal lymphadenitis without meningitis in an immunocompetent human immunodeficiency virus-negative child: a rare case report | |
| Jeetendra Gurung,Wihiwot Valarie Lyngdoh,Annie B. Khyriem |
| JMM Case Reports.2014;1(3)370 |
| [DOI] |
|
| 14 | Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence | |
| Jairo M. Montezuma-Rusca,John H. Powers,Dean Follmann,Jing Wang,Brigit Sullivan,Peter R. Williamson,Eliseo A Eugenin |
| PLOS ONE.2016;11(8)e0159727 |
| [DOI] |
|
| 15 | Treatment for HIV-associated cryptococcal meningitis | |
| Mark W Tenforde,Adrienne E Shapiro,Benjamin Rouse,Joseph N Jarvis,Tianjing Li,Ingrid Eshun-Wilson,Nathan Ford |
| Cochrane Database of Systematic Reviews.2018;2018(7)e0159727 |
| [DOI] |
|
| 16 | Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis | |
| Abeer H.A. Mohamed-Ahmed,Stephen Brocchini,Simon L. Croft |
| Current Opinion in Infectious Diseases.2012;25(6)695 |
| [DOI] |
|
| 17 | Nanomedicine: New Frontiers in Fighting Microbial Infections | |
| Mohammad Reza Mehrabi,Madjid Soltani,Mohsen Chiani,Kaamran Raahemifar,Ali Farhangi |
| Nanomaterials.2023;13(3)483 |
| [DOI] |
|
| 18 | Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) | |
| Markus Ruhnke,Oliver A. Cornely,Martin Schmidt-Hieber,Nael Alakel,Boris Boell,Dieter Buchheidt,Maximilian Christopeit,Justin Hasenkamp,Werner J. Heinz,Marcus Hentrich,Meinolf Karthaus,Michael Koldehoff,Georg Maschmeyer,Jens Panse,Olaf Penack,Jan Schleicher,Daniel Teschner,Andrew John Ullmann,Maria Vehreschild,Marie Lilienfeld-Toal,Florian Weissinger,Stefan Schwartz |
| Mycoses.2020;63(7)653 |
| [DOI] |
|
